Results 121 to 130 of about 22,441 (260)

Which infinite abelian groups admit an almost maximally almost-periodic group topology?

open access: yes, 2009
A topological group G is said to be almost maximally almost-periodic if its von Neumann radical n(G) is non-trivial, but finite. In this paper, we prove that every abelian group with an infinite torsion subgroup admits a (Hausdorff) almost maximally ...
Nguyen, A.P.
core   +1 more source

Specific early electroencephalogram for the diagnosis of sporadic Creutzfeldt-Jakob disease

open access: yesPrion
An early diagnosis is required for intervention in prion disease cases. To elucidate the specificity of early electroencephalography discharges in cases of sporadic Creutzfeldt-Jakob disease, we analysed epileptiform discharges through ...
Taiki Matsubayashi   +5 more
doaj   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Maximum Order of Periodic Outer Automorphisms of a Free Group

open access: yes, 2000
Let Fn be a free group with rank n, and denote by OutFn its outer automorphism group. For arbitrary n, consider the orders of periodic elements in OutFn or, equivalently, the orders of finite cyclic subgroups of OutFn.
Bao, Zhiqiang
core   +1 more source

Group work is not one, but a great many processes – Understanding group work dynamics

open access: yes, 2010
When people come together in order to collaborate with each other, lots of group processes arise.Earlier research has shown that group work is not just one single activity but is comprised of several activities with different goals and conditions.
Hammar Chiriac, Eva,
core   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

ON THE COHOMOLOGY OF WEAKLY ALMOST PERIODIC GROUP REPRESENTATIONS

open access: yes, 2014
. We initiate a study of cohomological aspects of weakly almost periodic group representations on Banach spaces, in particular, isometric rep-resentations on reflexive Banach spaces.
Roman Sauer   +2 more
core  

PERIOD BY THE WAVE-GROUP METHOD

open access: yesCoastal Engineering Proceedings, 1972
The wave-group period, T , is obtained by a eimple manual procedure from the periodic wave groupff'and sequences that appear in strip-chart records. A dozen or more values are commonly derived from a 20-minute record. When plotted as a time-series, T values form patterns that represent individual wave trains, each generated by a synoptic weather event.
openaire   +2 more sources

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy